Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1988 3
1991 1
1992 1
1993 1
1994 1
1996 2
1997 2
1999 5
2000 1
2001 2
2004 1
2015 2
2019 1
2020 1
2023 1
2024 4
2025 8
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
CAR T-cell therapy in large B cell lymphoma.
Boardman AP, Salles G. Boardman AP, et al. Hematol Oncol. 2023 Jun;41 Suppl 1(Suppl 1):112-118. doi: 10.1002/hon.3153. Hematol Oncol. 2023. PMID: 37294963 Free PMC article. Review.
Leucine zipper-based immunomagnetic purification of CAR T cells displaying multiple receptors.
James SE, Chen S, Ng BD, Fischman JS, Jahn L, Boardman AP, Rajagopalan A, Elias HK, Massa A, Manuele D, Nichols KB, Lazrak A, Lee N, Roche AM, McFarland AG, Petrichenko A, Everett JK, Bushman FD, Fei T, Kousa AI, Lemarquis AL, DeWolf S, Peled JU, Vardhana SA, Klebanoff CA, van den Brink MRM. James SE, et al. Among authors: boardman ap. Nat Biomed Eng. 2024 Dec;8(12):1592-1614. doi: 10.1038/s41551-024-01287-3. Epub 2024 Dec 23. Nat Biomed Eng. 2024. PMID: 39715901 Free PMC article.
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma.
Deschênes-Simard X, Bromberg M, Devlin SM, Gonen M, Beyar-Katz O, Ip A, Marcus R, Avigdor A, Ballweg A, Rabinovich E, Alhomoud M, Rivas Delgado A, Corona De Lapuerta M, Luna De Abia A, Palomba ML, Shah GL, Lin R, Boardman AP, Falchi L, Lue J, Salles G, Perales MA, Shouval R, Dahi PB, Scordo M. Deschênes-Simard X, et al. Among authors: boardman ap. Blood Adv. 2025 Nov 11;9(21):5571-5584. doi: 10.1182/bloodadvances.2025016778. Blood Adv. 2025. PMID: 40815804 Free PMC article.
Does BTKi improve CAR T-cell therapy in MCL?
Boardman AP, Palomba ML. Boardman AP, et al. Blood. 2024 Feb 22;143(8):653-655. doi: 10.1182/blood.2023022898. Blood. 2024. PMID: 38386430 Free article. No abstract available.
Barriers to Chimeric Antigen Receptor T-Cell Therapy.
Valtis YK, Chin KK, Nemirovsky D, Devlin SM, Yisraeli Salman M, Boussi L, Cadzin B, McLoughlin C, Cathcart E, Davis P, Brooklyn C, Goldstein T, Famulare C, Shah GL, Walji M, Scordo M, Boardman AP, Shouval R, Stein EM, Geyer MB, Mailankody S, Palomba ML, Usmani SZ, Salles G, Giralt SA, Perales MA, Park JH. Valtis YK, et al. Among authors: boardman ap. JAMA Oncol. 2025 Jul 1;11(7):781-784. doi: 10.1001/jamaoncol.2025.1127. JAMA Oncol. 2025. PMID: 40372728 Free PMC article.
Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell Lymphoma.
Hubbeling H, Leithner D, Silverman EA, Flynn J, Devlin S, Shah G, Fregonese B, Wills B, Bedmutha A, Alarcon Tomas A, Parascondola A, Saldia A, Landego I, Hajj C, Boardman AP, Dahi PB, Ghosh A, Giralt S, Lin RJ, Park J, Scordo M, Salles G, Yahalom J, Palomba ML, Schöder H, Perales MA, Shouval R, Imber BS. Hubbeling H, et al. Among authors: boardman ap. Clin Cancer Res. 2024 Nov 15;30(22):5083-5093. doi: 10.1158/1078-0432.CCR-24-0830. Clin Cancer Res. 2024. PMID: 39259292 Free PMC article.
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma.
Winkelmann M, Raj SS, Jain MD, Iacoboni G, Müller F, Hansmann L, Corona M, Luna A, Jhaveri K, Shah GL, Scordo M, Mohammad T, Dean EA, Sheikh GT, Kunz WG, Tix T, Bücklein VL, Bedmutha A, Leithner D, von Bergwelt-Baildon M, Boardman AP, Palomba ML, Park JH, Salles G, Perales MA, Schöder H, Subklewe M, Barba P, Locke FL, Shouval R, Rejeski K. Winkelmann M, et al. Among authors: boardman ap. Blood Cancer J. 2025 Aug 26;15(1):144. doi: 10.1038/s41408-025-01338-1. Blood Cancer J. 2025. PMID: 40858552 Free PMC article.
Patterns and safety of glucocorticosteroid use following CD19 CAR-T therapy for large B-cell lymphoma.
Luttwak E, Nemirovsky D, Devlin SM, Boardman AP, Cassanello G, Corona M, Luan D, Dahi PB, Abia AL, Falchi L, Landego I, Lin RJ, Lue JK, Palomba LM, Park JH, Raj SS, Rejeski K, Rivas Delgado A, Scordo M, Tomas AA, Shah GL, Perales MA, Salles G, Shouval R. Luttwak E, et al. Among authors: boardman ap. Hemasphere. 2025 Nov 27;9(11):e70248. doi: 10.1002/hem3.70248. eCollection 2025 Nov. Hemasphere. 2025. PMID: 41321357 Free PMC article.
Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.
Gomez-Llobell M, Shouval R, Brown S, Goan-Accav N, Devlin S, Corona M, Rejeski K, Rivas-Delgado A, Luna A, Luttwak E, Raj SS, Alhomoud M, Sanz J, Einarsdottir S, Marcus R, Shimoni A, Ringelstein-Harlev S, Khatib H, Boardman AP, Lue J, Dahi P, Lin R, Scordo M, Falchi L, Shah GL, Palomba ML, Salles G, Park JH, Beyar-Katz O, Avigdor A, Perales MA. Gomez-Llobell M, et al. Among authors: boardman ap. Transplant Cell Ther. 2026 Jun;32(6):676.e1-676.e14. doi: 10.1016/j.jtct.2026.02.058. Epub 2026 Feb 28. Transplant Cell Ther. 2026. PMID: 41765136
43 results